Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

December 01, 2017

Only 1 in 4 people living with HIV are receiving treatment in Guinea; without treatment, they can easily develop AIDS. Doctors Without Borders/Médecins Sans Frontières (MSF) supports a hospital in Conakry, Guinea, that treats those who have developed AIDS. Patients arrive very ill, often with opportunistic infections.

December 01, 2017

For many people in rural South Sudan, HIV testing and antiretroviral therapy (ART) is nearly impossible to obtain, partly because war has forced many to flee to isolated locations where treatment options are limited or nonexistent. But in Yambio County—in the southwest—things are different as a Doctors Without Borders/Médecins Sans Frontières (MSF) pilot project is providing same-day care to many people living with HIV.

November 30, 2017

For World Aids Day on December 1, 2017, Doctors Without Borders/Médecins Sans Frontières (MSF) is launching a national multimedia awareness campaign "Zwa Nga Bien" (Look at Me Well) aimed at young urban audiences in Democratic Republic of Congo to address the stigma still associated with HIV there. Music by Lexxus Legal and Sista Becky.

November 17, 2017

Since September, a cholera epidemic in Chad has followed the meandering path of the Bahr-Azoum river—used by many for washing, bathing, and even drinking—southward from the eastern Sila region to the more heavily populated district of Am Timan, in Salamat region, near the border with Central African Republic.

November 17, 2017

The Saudi-led coalition's continuing blockade of Yemen's ports and airports is significantly hindering the efforts of Doctors Without Borders/Médecins Sans Frontières (MSF) and other humanitarian organizations to provide lifesaving assistance to people in the war-torn country.

November 15, 2017

Ahead of the first-ever Global Ministerial Conference on “Ending TB” in Moscow, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF), the Stop TB Partnership, and tens of thousands of supporters called for countries with the most people affected by tuberculosis (TB) to implement the latest international treatment and testing standards by World TB Day, March 24, 2018.

November 14, 2017

Justin Armstrong, the Yemen country director for Doctors Without Borders/Médecins Sans Frontières (MSF), discusses the cholera outbreak and the effects of the blockade by the Saudi-led coalition. View External Media.

Read More: Yemen: Saudi-Led Coalition Must Allow Access for Humanitarian Organizations

November 13, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF), was told by the Pakistani authorities to close its medical activities in Bajaur Agency in north-western Pakistan. The closure will leave thousands of people in Bajaur Agency without access to free vital healthcare. The announcement comes just seven weeks after MSF was forced to close its project in Kurram Agency, also in the Federally Administered Tribal Areas (FATA).

November 01, 2017

The spread of hepatitis E in Niger’s Diffa region has slowed since Doctors Without Borders/Médecins Sans Frontières (MSF) first began detecting and treating cases in early 2017, and the subsequent declaration of the outbreak by the Ministry of Health (MoH) in mid-April. Through a combination of active case finding, quicker diagnoses, a medical protocol, and working with the community through a network of volunteers, the case fatality rate has fallen.

October 31, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) announced today it can now purchase generic hepatitis C medicines for as low as $1.40 per day, or $120 per 12-week treatment course, for two key medicines used to treat and cure this disease, sofosbuvir and daclatasvir. This dramatic price reduction—which will benefit patients in countries where MSF can supply generic versions—illustrates the importance of generic options, which could, if expanded, help countries provide treatment for millions of people and improve public health by preventing the spread of this disease.

Pages